Clinical Trial Update: Effect of Probucol and/or Cilostazol on Mean IMT in Patients With Coronary Heart dIsease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effects of probucol and/or cilostazol on mean intima-media thickness in patients with coronary heart disease and hyperli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Hyperlipidemia

Drugs mentioned

• Cilostazol (Cilostazol)
• Probucol (Probucol)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Hyperlipidemias | Phase 4 | Status: COMPLETED